Presentation is loading. Please wait.

Presentation is loading. Please wait.

The US Food and Drug Administration review of the safety and effectiveness of nonstandardized allergen extracts  Jay E. Slater, MD, Sandra L. Menzies,

Similar presentations


Presentation on theme: "The US Food and Drug Administration review of the safety and effectiveness of nonstandardized allergen extracts  Jay E. Slater, MD, Sandra L. Menzies,"— Presentation transcript:

1 The US Food and Drug Administration review of the safety and effectiveness of nonstandardized allergen extracts  Jay E. Slater, MD, Sandra L. Menzies, MS, Jennifer Bridgewater, MPH, Alexis Mosquera, RN, MPH, Craig E. Zinderman, MD, MPH, Alan C. Ou, MD, MPH, Diane Maloney, JD, Catherine M. Cook, JD, Ronald L. Rabin, MD  Journal of Allergy and Clinical Immunology  Volume 129, Issue 4, Pages (April 2012) DOI: /j.jaci Copyright © Terms and Conditions

2 Fig 1 Adverse event reports associated with injection of allergen extracts by year from 1987 through mid The total number of adverse event reports received during this period was 178. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © Terms and Conditions

3 Fig 2 Adverse events associated with injection of allergen extracts by allergen extract type. Note that some reports indicated more than 1 suspect product. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © Terms and Conditions


Download ppt "The US Food and Drug Administration review of the safety and effectiveness of nonstandardized allergen extracts  Jay E. Slater, MD, Sandra L. Menzies,"

Similar presentations


Ads by Google